Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Elmer

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Life Sciences|January 1, 1977
Biliary excretion of warfarin metabolites and their metabolism by rat gut floraM L Powell, B Pope, G W Elmer, et al.
Pharmaceutical Research|June 1, 1991
Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in ratsA V Boddy, G W Elmer, L V McFarland, et al.
Infection and Immunity|July 1, 1991
Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patientsL V McFarland, G W Elmer, W E Stamm, et al.
Digestive Diseases and Sciences|July 1, 1990
Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardiiM B Kimmey, G W Elmer, C M Surawicz, et al.
Journal of General Microbiology|June 1, 1990
Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological studyF Castex, G Corthier, S Jouvert, et al.
Cancer Research|November 1, 1978
Increased tyrosine phenol-lyase activity in mice following pyridoxal phosphate administrationG W Elmer, L Minor, G G Meadows, et al.
Infection and Immunity|December 1, 1989
Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic miceG Corthier, M C Muller, G W Elmer, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patientsG W Elmer, L V McFarland, C M Surawicz, et al.
Medical Hypotheses|December 12, 2001
Does gastrointestinal Candida albicans prevent ubiquinone absorption?C A Krone, G W Elmer, J T Ely, et al.
Pharmaceutical Research|November 1, 1993
Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteersS M Klein, G W Elmer, L V McFarland, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Life Sciences|January 1, 1977
Biliary excretion of warfarin metabolites and their metabolism by rat gut floraM L Powell, B Pope, G W Elmer, et al.
Pharmaceutical Research|June 1, 1991
Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in ratsA V Boddy, G W Elmer, L V McFarland, et al.
Infection and Immunity|July 1, 1991
Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patientsL V McFarland, G W Elmer, W E Stamm, et al.
Digestive Diseases and Sciences|July 1, 1990
Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardiiM B Kimmey, G W Elmer, C M Surawicz, et al.
Journal of General Microbiology|June 1, 1990
Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological studyF Castex, G Corthier, S Jouvert, et al.
Cancer Research|November 1, 1978
Increased tyrosine phenol-lyase activity in mice following pyridoxal phosphate administrationG W Elmer, L Minor, G G Meadows, et al.
Infection and Immunity|December 1, 1989
Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic miceG Corthier, M C Muller, G W Elmer, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patientsG W Elmer, L V McFarland, C M Surawicz, et al.
Medical Hypotheses|December 12, 2001
Does gastrointestinal Candida albicans prevent ubiquinone absorption?C A Krone, G W Elmer, J T Ely, et al.
Pharmaceutical Research|November 1, 1993
Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteersS M Klein, G W Elmer, L V McFarland, et al.
Pageof 4